Valuation: Bayer AG

Capitalization 39.41B 46.27B 36.48B 34.35B 63.97B 4,303B 65.29B 428B 167B 2,066B 174B 170B 7,362B P/E ratio 2026 *
20x
P/E ratio 2027 * 12.9x
Enterprise value 71.65B 84.1B 66.31B 62.43B 116B 7,822B 119B 778B 304B 3,756B 316B 309B 13,384B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.47x
Free-Float
100%
Yield 2026 *
0.55%
Yield 2027 * 1.91%
1 day-0.82%
1 week+1.07%
Current month+1.87%
1 month+0.26%
3 months+3.19%
6 months+43.39%
Current year+8.40%
1 week 39.09
Extreme 39.09
41.14
1 month 36.88
Extreme 36.875
41.14
Current year 35.2
Extreme 35.2
49.78
1 year 20.47
Extreme 20.47
49.78
3 years 18.38
Extreme 18.378
61.91
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 56 01/06/2018
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 69 01/04/2002
Director/Board Member 55 01/04/2012
Director/Board Member 66 01/04/2022
Change 5d. change 1-year change 3-years change Capi.($)
-0.82%+1.07%+99.01%-33.49% 46.27B
-1.65%+0.42%+28.27%+158.07% 841B
-1.18%-1.88%+57.16%+45.16% 574B
-2.10%-0.43%+18.79%+28.85% 368B
-0.09%0.00%+30.43%+16.21% 320B
-0.30%-0.56%+52.18%+30.95% 318B
-1.03%+0.46%+53.35%+7.94% 300B
-0.34%-1.17%+41.43%+40.20% 295B
-1.29%+0.89%+22.74%+39.61% 189B
-2.18%-0.52%+34.12%+68.39% 173B
Average -1.10%+0.36%+43.75%+40.19% 342.41B
Weighted average by Cap. -1.18%+0.02%+38.80%+63.21%

Financials

2026 *2027 *
Net sales 45.38B 53.27B 42B 39.54B 73.66B 4,954B 75.16B 493B 193B 2,379B 200B 196B 8,477B 46.63B 54.74B 43.16B 40.63B 75.69B 5,091B 77.24B 506B 198B 2,445B 205B 201B 8,710B
Net income 1.93B 2.26B 1.78B 1.68B 3.13B 210B 3.19B 20.91B 8.18B 101B 8.49B 8.31B 360B 3.03B 3.55B 2.8B 2.64B 4.91B 331B 5.01B 32.87B 12.86B 159B 13.34B 13.05B 566B
Net Debt 32.23B 37.84B 29.83B 28.09B 52.32B 3,519B 53.39B 350B 137B 1,690B 142B 139B 6,021B 29.32B 34.42B 27.14B 25.55B 47.59B 3,201B 48.57B 318B 125B 1,537B 129B 126B 5,477B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,280
Date Price Change Volume
10/04/26 40.12 -0.82% 2,159,682
09/04/26 40.45 -0.07% 1,855,752
08/04/26 40.48 +3.08% 2,821,861
07/04/26 39.27 -1.07% 2,358,730
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
40.12EUR
Average target price
46.53EUR
Spread / Average Target
+15.97%

Quarterly revenue - Rate of surprise